ClinicalTrials.Veeva

Menu

Breath Gas Analysis for the Diagnosis of Breast Cancer

I

Ionimed Analytik

Status

Terminated

Conditions

Mamma Carcinoma

Treatments

Device: Breath Collecting Unit

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically analyzed by proton-transfer-reaction time of flight mass spectrometry.

The goal of the study is to determine typical breath gas components that allow to distinguish patients with mamma carcinoma from women without carcinoma. Further, the investigators will test whether these breath gas markers can be used as tumor markers, which change in a typical manner during the progress of the disease. Finally the data will be investigated for the presence of marker components, that identify patients who will develop metastasis.

Enrollment

202 patients

Sex

Female

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Mamma carcinoma diagnosed by histology (cases)
  • Mamma carcinoma excluded by radiology (controls)
  • At the time of diagnosis before surgery
  • At the beginning and during chemotherapy;

Exclusion criteria

  • No informed consent form singed

Trial design

202 participants in 3 patient groups

Mamma Carcinoma, no treatment
Treatment:
Device: Breath Collecting Unit
Device: Breath Collecting Unit
Mamma Carcinoma, treatment
Treatment:
Device: Breath Collecting Unit
Device: Breath Collecting Unit
No Mamma Carcinoma diagnosed by X-ray
Treatment:
Device: Breath Collecting Unit
Device: Breath Collecting Unit

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems